Trial Profile

Assessment of Safety and Efficacy of Levemir (Insulin Detemir) Treatment for Insulin Naive Patients With Type 2 Diabetes Mellitus.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin detemir (Primary)
Indications Type 2 diabetes mellitus
Focus Adverse reactions
Acronyms IDEALS
Sponsors Novo Nordisk

Most Recent Events

26 Jul 2011 Actual end date changed from Jul 2009 to Sep 2009 as reported by ClinicalTrials.gov
26 Jul 2011 Actual initiation date changed from Jun 2008 to Jan 2008 as reported by ClinicalTrials.gov.
02 Sep 2009 Actual end date (July 2009) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com